Roles of lncRNAs in NF-κB-Mediated Macrophage Inflammation and Their Implications in the Pathogenesis of Human Diseases

Jae-Joon Shin,Jeongkwang Park,Hyeung-Seob Shin,Imene Arab,Kyoungho Suk,Won-Ha Lee
DOI: https://doi.org/10.3390/ijms25052670
IF: 5.6
2024-02-26
International Journal of Molecular Sciences
Abstract:Over the past century, molecular biology's focus has transitioned from proteins to DNA, and now to RNA. Once considered merely a genetic information carrier, RNA is now recognized as both a vital element in early cellular life and a regulator in complex organisms. Long noncoding RNAs (lncRNAs), which are over 200 bases long but do not code for proteins, play roles in gene expression regulation and signal transduction by inducing epigenetic changes or interacting with various proteins and RNAs. These interactions exhibit a range of functions in various cell types, including macrophages. Notably, some macrophage lncRNAs influence the activation of NF-κB, a crucial transcription factor governing immune and inflammatory responses. Macrophage NF-κB is instrumental in the progression of various pathological conditions including sepsis, atherosclerosis, cancer, autoimmune disorders, and hypersensitivity. It orchestrates gene expression related to immune responses, inflammation, cell survival, and proliferation. Consequently, its malfunction is a key contributor to the onset and development of these diseases. This review aims to summarize the function of lncRNAs in regulating NF-κB activity in macrophage activation and inflammation, with a particular emphasis on their relevance to human diseases and their potential as therapeutic targets. The insights gained from studies on macrophage lncRNAs, as discussed in this review, could provide valuable knowledge for the development of treatments for various pathological conditions involving macrophages.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the role of long non - coding RNAs (lncRNAs) in NF - κB - mediated macrophage inflammatory responses and their significance in the pathogenesis of human diseases. Specifically, the paper focuses on the following aspects: 1. **Functions of lncRNAs**: The paper summarizes the role of lncRNAs in regulating NF - κB activity in macrophages, especially how these lncRNAs affect the inflammatory response by directly or indirectly interacting with NF - κB or its signaling pathway components. 2. **Inflammation - related diseases**: The paper emphasizes the potential role of lncRNAs in various inflammation - related diseases, including sepsis, atherosclerosis, cancer, autoimmune diseases, and hypersensitivity reactions. The occurrence and development of these diseases are closely related to the macrophage inflammatory response, and NF - κB is a key transcription factor in regulating this process. 3. **Therapeutic targets**: The paper explores the potential of lncRNAs as targets for disease diagnosis, prognosis, and treatment. By regulating the expression of lncRNAs, the activity of NF - κB can be affected, which may provide new strategies for treating these inflammation - related diseases. ### Specific research contents 1. **lncRNAs in sepsis**: - **NEAT1**: In patients with sepsis, the level of NEAT1 is significantly increased. It stabilizes TLR4 mRNA by sponging miR - 17 - 5p, enhancing the inflammatory response. In addition, NEAT1 promotes M1 polarization through the miR - 125a - 5p/TRAF6/TAK1 axis. - **MALAT1**: In patients with advanced sepsis, the level of MALAT1 in the blood is related to the severity of the disease. The expression of MALAT1 is increased in activated macrophages, and reducing MALAT1 can alleviate inflammation and reduce mortality. - **PVT1**: The expression level of PVT1 in patients with sepsis is increased, and it enhances NF - κB activity through p38 stimulation, promoting M1 polarization. - **MEG3**: The expression level of MEG3 in patients with sepsis is significantly decreased, and over - expressing MEG3 can inhibit LPS - induced apoptosis and the expression of inflammatory factors. - **CRNDE**: The expression level of CRNDE in the peripheral blood of patients with sepsis is increased, and it enhances LPS - induced NF - κB activation and the release of pro - inflammatory cytokines through the miR - 181 - 5p/TLR4 axis. 2. **lncRNAs in atherosclerosis**: - **NEAT1**: In patients with atherosclerosis, the expression level of NEAT1 is significantly increased. It promotes the inflammatory response by enhancing p65 phosphorylation and forming paraspeckles. NEAT1 also promotes foam cell formation through the miR - 342 - 3p and miR - 128 axes. - **PVT1**: The expression level of PVT1 in patients with atherosclerosis is increased, and inhibiting PVT1 can reduce the formation of atherosclerotic plaques by increasing HDL levels and inhibiting the MAPK/NF - κB pathway. - **SNHG16**: The expression level of SNHG16 in patients with atherosclerosis is increased, and it amplifies macrophage proliferation and the pro - inflammatory response through the miR - 17 - 5p/NF - κB axis. - **XIST**: The role of XIST in atherosclerosis is still under study, and preliminary results show that it may participate in the disease process by affecting NF - κB activity. ### Conclusion By reviewing the role of lncRNAs in NF - κB - mediated macrophage inflammatory responses, this paper reveals the potential mechanisms of these molecules in various inflammation - related diseases and explores their potential as therapeutic targets. This provides an important theoretical basis for the development of new treatment methods for these diseases.